Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Amiloride disposition in geriatric patients: importance of renal function.

Author information

Affiliations

  • 1. Department of Clinical Pharmacology, Royal Adelaide Hospital, Australia.
      Authors
    • Somogyi A 1
    (1 author)

British Journal of Clinical Pharmacology, 01 Jan 1990, 29(1):1-8
https://doi.org/10.1111/j.1365-2125.1990.tb03595.x PMID: 2297454 PMCID: PMC1380054

Free full text in Europe PMC

Abstract 

1. The absorption and disposition of the potassium sparing diuretic amiloride were determined in nine elderly patients aged 71 to 87 years and in eight young (25 to 38 years) subjects following oral administration of 5 mg amiloride HCl daily to steady-state. 2. The maximum and steady-state plasma amiloride concentrations were significantly (P less than 0.05 and P less than 0.001) higher in the elderly patients. The renal clearance of amiloride was lower in the elderly than in young subjects (102 +/- 36 ml min -1 vs 300 +/- 64 ml min-1, P less than 0.001) as was the urinary excretion of amiloride (36 +/- 13 vs 62 +/- 18% of the dose, P less than 0.01). 3. The steady-state plasma amiloride concentration correlated significantly (r2 = 0.61, P less than 0.001) with amiloride renal clearance and with creatinine clearance (r2 = 0.59, P less than 0.001). There was a very strong positive correlation between renal amiloride clearance and creatinine clearance (r2 = 0.76, P less than 0.001). The slope of the regression line was 2.5 indicating substantial proximal tubular secretion of amiloride. 4. Sodium and potassium excretion, along with urine volume were significantly (P less than 0.05) lower in the elderly (by 39, 45 and 34% respectively). 5. The disposition of amiloride was highly dependent on renal function, with higher plasma amiloride concentrations in the elderly reflecting diminished renal function. The dose of amiloride should be titrated to individual response, and the lower potassium excretion in the elderly patients suggests that the dose of amiloride could be reduced in this group of patients.

Free full text 

Logo of brjclinpharmLink to Publisher's site
Br J Clin Pharmacol. 1990 Jan; 29(1): 1–8.
PMCID: PMC1380054
PMID: 2297454

Amiloride disposition in geriatric patients: importance of renal function.

A Somogyi, D Hewson, M Muirhead, and F Bochner
Author information Copyright and License information Disclaimer

Abstract

1. The absorption and disposition of the potassium sparing diuretic amiloride were determined in nine elderly patients aged 71 to 87 years and in eight young (25 to 38 years) subjects following oral administration of 5 mg amiloride HCl daily to steady-state. 2. The maximum and steady-state plasma amiloride concentrations were significantly (P less than 0.05 and P less than 0.001) higher in the elderly patients. The renal clearance of amiloride was lower in the elderly than in young subjects (102 +/- 36 ml min -1 vs 300 +/- 64 ml min-1, P less than 0.001) as was the urinary excretion of amiloride (36 +/- 13 vs 62 +/- 18% of the dose, P less than 0.01). 3. The steady-state plasma amiloride concentration correlated significantly (r2 = 0.61, P less than 0.001) with amiloride renal clearance and with creatinine clearance (r2 = 0.59, P less than 0.001). There was a very strong positive correlation between renal amiloride clearance and creatinine clearance (r2 = 0.76, P less than 0.001). The slope of the regression line was 2.5 indicating substantial proximal tubular secretion of amiloride. 4. Sodium and potassium excretion, along with urine volume were significantly (P less than 0.05) lower in the elderly (by 39, 45 and 34% respectively). 5. The disposition of amiloride was highly dependent on renal function, with higher plasma amiloride concentrations in the elderly reflecting diminished renal function. The dose of amiloride should be titrated to individual response, and the lower potassium excretion in the elderly patients suggests that the dose of amiloride could be reduced in this group of patients.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (939K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
icon of scanned page 1
1
icon of scanned page 2
2
icon of scanned page 3
3
icon of scanned page 4
4
icon of scanned page 5
5
icon of scanned page 6
6
icon of scanned page 7
7
icon of scanned page 8
8
 

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Besseghir K, Rennick B. Renal tubule transport and electrolyte effects of amiloride in the chicken. J Pharmacol Exp Ther. 1981 Nov;219(2):435–441. [Abstract] [Google Scholar]
  • Drayer DE, Romankiewicz J, Lorenzo B, Reidenberg MM. Age and renal clearance of cimetidine. Clin Pharmacol Ther. 1982 Jan;31(1):45–50. [Abstract] [Google Scholar]
  • George CF. Amiloride handling in renal failure. Br J Clin Pharmacol. 1980 Jan;9(1):94–95. [Europe PMC free article] [Abstract] [Google Scholar]
  • Greenblatt DJ, Sellers EM, Shader RI. Drug therapy: drug disposition in old age. N Engl J Med. 1982 May 6;306(18):1081–1088. [Abstract] [Google Scholar]
  • Ho PC, Triggs EJ. Drug therapy in the elderly. Aust N Z J Med. 1984 Apr;14(2):179–190. [Abstract] [Google Scholar]
  • Lant A. Diuretics. Clinical pharmacology and therapeutic use (Part I). Drugs. 1985 Jan;29(1):57–87. [Abstract] [Google Scholar]
  • Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc. 1985 Apr;33(4):278–285. [Abstract] [Google Scholar]
  • Lynn KL, Bailey RR, Swainson CP, Sainsbury R, Low WI. Renal failure with potassium-sparing diuretics. N Z Med J. 1985 Aug 14;98(784):629–633. [Abstract] [Google Scholar]
  • MacFarlane JP, Kennedy RD. The effects of amiloride during diuretic therapy in elderly subjects. Age Ageing. 1972 May;1(2):103–110. [Abstract] [Google Scholar]
  • Muirhead MR, Somogyi AA, Rolan PE, Bochner F. Effect of cimetidine on renal and hepatic drug elimination: studies with triamterene. Clin Pharmacol Ther. 1986 Oct;40(4):400–407. [Abstract] [Google Scholar]
  • Mutschler E, Gilfrich HJ, Knauf H, Möhrke W, Völger KD. Pharmacokinetics of triamterene. Clin Exp Hypertens A. 1983;5(2):249–269. [Abstract] [Google Scholar]
  • Ouslander JG. Drug therapy in the elderly. Ann Intern Med. 1981 Dec;95(6):711–722. [Abstract] [Google Scholar]
  • Rennick B, Ziemniak J, Smith I, Taylor M, Acara M. Tubular transport and metabolism of cimetidine in chicken kidneys. J Pharmacol Exp Ther. 1984 Feb;228(2):387–392. [Abstract] [Google Scholar]
  • Reidenberg MM, Camacho M, Kluger J, Drayer DE. Aging and renal clearance of procainamide and acetylprocainamide. Clin Pharmacol Ther. 1980 Dec;28(6):732–735. [Abstract] [Google Scholar]
  • Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW. The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol. 1976 Mar;31(2):155–163. [Abstract] [Google Scholar]
  • Sabanathan K, Castleden CM, Adam HK, Ryan J, Fitzsimons TJ. A comparative study of the pharmacokinetics and pharmacodynamics of atenolol, hydrochlorothiazide and amiloride in normal young and elderly subjects and elderly hypertensive patients. Eur J Clin Pharmacol. 1987;32(1):53–60. [Abstract] [Google Scholar]
  • Smith AJ, Smith RN. Kinetics and bioavailability of two formulations of amiloride in man. Br J Pharmacol. 1973 Aug;48(4):646–649. [Europe PMC free article] [Abstract] [Google Scholar]
  • Somogyi AA, Hovens CM, Muirhead MR, Bochner F. Renal tubular secretion of amiloride and its inhibition by cimetidine in humans and in an animal model. Drug Metab Dispos. 1989 Mar-Apr;17(2):190–196. [Abstract] [Google Scholar]
  • Somogyi A, Keal J, Bochner F. Sensitive high-performance liquid chromatographic assay for determination of amiloride in biologic fluids using an ion-pair extraction method. Ther Drug Monit. 1988;10(4):463–468. [Abstract] [Google Scholar]
  • Spahn H, Reuter K, Mutschler E, Gerok W, Knauf H. Pharmacokinetics of amiloride in renal and hepatic disease. Eur J Clin Pharmacol. 1987;33(5):493–498. [Abstract] [Google Scholar]
  • Sunderam SG, Mankikar GD. Hyponatraemia in the elderly. Age Ageing. 1983 Feb;12(1):77–80. [Abstract] [Google Scholar]
  • Weiss P, Hersey RM, Dujovne CA, Bianchine JR. The meetabolism of amiloride hydroloride in man. Clin Pharmacol Ther. 1969 May-Jun;10(3):401–406. [Abstract] [Google Scholar]
  • Whiting GF, McLaran CJ, Bochner F. Severe hyperkalaemia with Moduretic. Med J Aust. 1979 May 5;1(9):409–409. [Abstract] [Google Scholar]
Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

Full text links 

Read article at publisher's site: https://doi.org/10.1111/j.1365-2125.1990.tb03595.x

Read article for free, from open access legal sources, via Unpaywall: https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.1990.tb03595.xUnpaywall

Citations & impact 

Impact metrics

11
Citations
Jump to Citations

Citations of article over time

Article citations

Go to all (11) article citations

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.